Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2025-10-21 00:00:00 ET · period of report 2025-10-20 · accession 0001193125-25-245262 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-10-21 | 2025-10-20 | CRBP | Altmeyer Anne | Dir | M - OptEx | $4.80 | +1,060 | 7,251 | +17% | +$5,088 |
| DT | 2025-10-21 | 2025-10-20 | CRBP | Altmeyer Anne | Dir | S - Sale+OE | $20.50 | -1,060 | 6,191 | -15% | -$21.7K |
| DT | 2025-10-21 | 2025-10-20 | CRBP | Altmeyer Anne | Dir | M - OptEx | $0.00 | -1,060 | 4,247 | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2025-10-20 | M | A | 1,060 | $4.80 | 7,251 | D | — | — | (F1) This amount includes 4,800 unvested RSUs that were granted on May 30, 2025 and vest 100% on the one-year anniversary of the date of grant. |
| 2 | Common | Common Stock, par value $0.0001 per share | 2025-10-20 | S | D | 1,060 | $20.50 | 6,191 | D | — | — | (F1) This amount includes 4,800 unvested RSUs that were granted on May 30, 2025 and vest 100% on the one-year anniversary of the date of grant. |
| 3 | Derivative | Stock options (right to buy) | 2025-10-20 | M | D | 1,060 | $0.00 | 4,247 | D | $4.80 · — to 2032-09-26 | 1,060 Common Stock | (F3) The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested. |